Rachel Amouroux

Dr. Amouroux graduated from Université Pierre et Marie Curie (Paris VI, France) and from the Institut National des Sciences Appliquées (INSA) in Lyon (France) in 2004. After being granted a PhD in Genetics for her work on DNA repair in collaboration with the Commissariat à l’Energie Atomique (CEA) and Paris VI, she spent 7 years as a research associate at Imperial College London, UK, working on the optimization of a new UHPLC/MS method for the quantification of DNA modifications in embryos during development. Her academic track-record on epigenetics and DNA modifications has been acknowledged in top international peer-reviewed journals.

Dr. Amouroux joined Inoviem Scientific in 2016 as Head of R&D to develop Inoviem’s proprietary technology NPOT® (Nematic Protein Organization Technique) that aims at isolating and identifying therapeutic targets, and deciphering drugs’ mode of action.